SlideShare a Scribd company logo
The public health response to increasing
syphilis trends in Europe
Otilia Mårdh, Gianfranco Spiteri, Aitana Morano-Vazquez, Andrew Amato
ECDC
IUSTI 2019, Tallinn
S18 - ECDC Symposium: Responding to two of the main STI threats of our time: syphilis and antimicrobial resistant
Neisseria gonorrhoeae
Background
• Since 2010, substantial increases in syphilis notifications
rates in EU, mainly MSM;
• Increasing trends and outbreaks also in other high-income
countries (e.g. US, Japan, Canada, Australia)
• September 2018 – request of Member States to ECDC
(update on epidemiology, options for response)
• July 2019 – ECDC technical report
2
Methods
Update on syphilis
epidemiology
Non-systematic literature
review *
2007-2018
PubMed, Embase, Scopus
Identify trends, describe recent
outbreaks,
identify drivers of syphilis
epidemic
Surveillance data analysis
2007-2017
ECDC TESSy
Member States survey
2019
Changes in surveillance,
recent data
3
*EU/EEA, EU candidate countries, high-income countries (Australia, Canada, Japan, New Zealand and the USA)
Options for response
Systematic literature review*
2007-2018
PubMed, Embase, Scopus,
Cochrane, Google-, hand-
searches
Member States survey
2019
Models of practice
Collect the evidence-base and
formulate options for response
Source: ECDC Syphilis and congenital syphilis in Europe - A review of epidemiological trends (2007–2018) and options for response. 2019
Objectives Outcomes
Syphilis epidemiology, 2007-2018
EU/EEA and high income countries
4
Syphilis EU/EEA, 2007-2017
5
0.0
2.0
4.0
6.0
8.0
10.0
12.0
14.0
2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Men
Total
Women
*not from Liechtenstein
Rates of syphilis infections per 100,000 population by year of
notification, EU/EEA countries
Note: includes reports from countries with comprehensive surveillance systems and consistent reporting over the period:
Bulgaria, Cyprus, the Czech Republic, Denmark, Estonia, Finland, Germany, Iceland, Ireland, Italy, Latvia, Lithuania,
Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden and the United Kingdom.
Source: ECDC Surveillance Atlas https://atlas.ecdc.europa.eu/public/index.aspx
• 260,505 syphilis cases, 30/31
Member States*
• EU/EEA rate from 4.6 in 2007 to
7.1 in 2017
• 260,505 syphilis cases, 30/31
Member States*
• EU/EEA rate from 4.6 in 2007 to
7.1 in 2017
• M:F 3 in 2007 to 8.5 in 2017
Syphilis EU/EEA, 2007-2017
6
0.0
2.0
4.0
6.0
8.0
10.0
12.0
14.0
2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Men
Total
Women
*not from Liechtenstein
Rates of syphilis infections per 100,000 population by year of
notification, EU/EEA countries
Note: includes reports from countries with comprehensive surveillance systems and consistent reporting over the period:
Bulgaria, Cyprus, the Czech Republic, Denmark, Estonia, Finland, Germany, Iceland, Ireland, Italy, Latvia, Lithuania,
Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden and the United Kingdom.
Source: ECDC Surveillance Atlas https://atlas.ecdc.europa.eu/public/index.aspx
0
2000
4000
6000
8000
10000
12000
14000
16000
2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Numberofcases
MSM
Heterosexual men
Women
Syphilis EU/EEA, 2007-2017
7
Number of syphilis infections by route of transmission*
Note: includes reports from Cyprus, the Czech Republic, Denmark, France, Germany, Iceland, Ireland, Latvia, Lithuania, Malta, the
Netherlands, Norway, Romania, Slovenia, Sweden and the United Kingdom.
*Reported for 152,233 (58%) cases
Overall, 2007-2017
MSM 62% 94,015
Heterosexual men 23% 35,633
Women 15% 22,242
Source: ECDC Surveillance Atlas https://atlas.ecdc.europa.eu/public/index.aspx
Syphilis EU/EEA, 2014- 2017
2014 2015 2016 2017
Women 2.6% 2.1% 3.1% 1.8%
Heterosexual men 12% 12% 10% 10%
MSM 45% 44% 41% 39%
8
HIV co-infection
*includes 39,340 cases with known HIV status reported as MSM, heterosexual men
and heterosexual women between 2014-2017.
Source: ECDC Surveillance Atlas https://atlas.ecdc.europa.eu/public/index.aspx
Percentage HIV-positive syphilis cases*
0
1000
2000
3000
4000
5000
6000
2014 2015 2016 2017
Numberofcases
MSM HIV-
MSM HIV+
Number of syphilis infections by HIV-status among MSM
Syphilis EU/EEA, 2014-2017
9
0%
10%
20%
30%
40%
50%
60%
Women (n=3,986) Heterosexual men
(n=6,136)
MSM (n=24,278)
Percentage
Primary
Secondary
Early latent
Late latent
Latent (unknown duration)
Stage of syphilis infection at diagnosis
Note: includes reports from the Czech Republic, France, Hungary,
Iceland, Ireland, Latvia, Lithuania, Luxembourg, Malta, the
Netherlands, Norway, Portugal, Romania, Slovakia, Slovenia,
Sweden, the United Kingdom
• Most cases reported as early latent infection
• 49% of women as early latent infections
• Primary stage: 35% MSM, 31% MSW, 15%
WSM
Source: ECDC Surveillance Atlas https://atlas.ecdc.europa.eu/public/index.aspx
10
Literature review on syphilis epidemiology
Studies reporting increasing trends and outbreaks by country and year of publication
Note: search conducted in PubMed, Embase, Scopus 2007-2018; studies
from the EU/EEA, EU candidate countries, high-income countries:
Australia, Canada, Japan, New Zealand and the USA. Five studies with
multi-country coverage not represented.
Trends Outbreaks
Australia 3 3
Canada 3 2
Switzerland 1
Czech Republic 1
Germany 2
Spain 7
Finland 1
France 2
Greece 1 2
Ireland 1
Japan 1
Netherlands 1 1
New Zeeland 3
Poland 1
Portugal 1
Romania 2
Serbia 1
UK 8 13
USA 20 7
Total 59 29
Source: ECDC Syphilis and congenital syphilis in Europe - A review of epidemiological trends (2007–2018) and options for response. 2019
• 19 countries, 14 European
11
Literature review on syphilis epidemiology
Studies reporting increasing trends/outbreaks by risk group, country and year of publication
Note: search conducted in PubMed, Embase, Scopus 2007-2018; studies from the
EU/EEA, EU candidate countries, high-income countries: Australia, Canada, Japan,
New Zealand and the USA.
* Other includes: sex workers, military, blood donors, prisoners, PWID
Heterosexuals
HIV-positive
Migrants
MSM,bisexuals
Other*
Pregnantwomen
Albania 2
Belgium 1
Canada 2 1
France 1 1
Germany 2 2
Greece 1
Ireland 1
Italy 1 1 2
Poland 2 2
Romania 1
Serbia 1
Spain 3 2 2 1
Sweden 1
Switzerland 2 1
Netherlands 2
UK 1 3
USA 6 8 7 4 3
Total 6 21 5 17 13 8
Source: ECDC Syphilis and congenital syphilis in Europe - A review of epidemiological trends (2007–2018) and options for response. 2019
• 68 studies, 17 countries
Factors driving syphilis increases in EU/EEA and high income
countries, 2007-2018, literature review results
• high rates of condomless sex
• increased number of sex partners (HIV-
negative MSM)
• serosorting (HIV-positive MSM)
• impact of PrEP for HIV
• use of social networking sites or mobile
device application
12
Source: ECDC Syphilis and congenital syphilis in Europe - A review of epidemiological trends (2007–2018) and options for response. 2019
• condomless sex
• multiple sex partners
• substance use (drug or alcohol)
• young age
• history of incarceration
• sex work
• previous STI
• social vulnerabilities (e.g. poverty,
homelessness, ethnic minority, migrant or
refugee status)
MSM Heterosexual men and women
Katsushika Hokusai. The Great Wave off Kanagawa
Options for response
How can we turn the tide?
13
2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
14
0
2
4
6
8
10
12
2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
No.ofstudies
Year of publication
Biomedical interventions
Interventions using social media
Education
Partner notification
Outreach venues testing
Screening
Source: ECDC Syphilis and congenital syphilis in Europe - A review of epidemiological trends (2007–2018) and options for response. 2019
Screening
Outreachvenuestesting
Partnernotification
Education
Socialmedia
Biomedical
Australia 5 3 1
France 1
Ireland 1
Netherlands 1
New Zeeland 1
UK 1 4 1
USA 8 1 6 11 4 1
Total 15 5 6 15 6 3
Systematic literature review on response interventions
Studies reporting single interventions with a documented impact among adult populations
Note: search conducted in PubMed, Embase,
Scopus, CDSR, Google, hand searches; studies from
the EU/EEA, EU candidate countries, high-income
countries: Australia, Canada, Japan, New Zealand
and the USA. Nine other studies reporting
multiple interventions for outbreak response
summarised in the report.
• 50 studies, 7 countries
Public health responses to increases in syphilis should aim to identify and treat
syphilis cases and prevent new infections.
Combining,
15
Case finding
Screening/testing
Partner notification and
management
Surveillance
Case management
Appropriate treatment
Risk reduction counseling
Education
General population
Populations at higher risk
Healthcare providers
Source: ECDC Syphilis and congenital syphilis in Europe - A review of epidemiological trends (2007–2018) and options for response. 2019




1. Enhanced screening of populations at risk
Testing of other risk groups e.g. ethnic minorities, marginalised populations, sex workers, PWID - to be
informed by local epidemiology
16
Source: ECDC Syphilis and congenital syphilis in Europe - A review of epidemiological trends (2007–2018) and options for response. 2019
Population Intervention Outcome
HIV-positive MSM Include syphilis testing in routine HIV
clinical monitoring, 3- or 6-monthly, opt-
out vs risk based Increase detection of
early/asymptomatic syphilis
infections
HIV-negative MSM
• with high no. of sex partners
• PrEP users
• with prior syphilis diagnosis
Quarterly testing vs. bi-annual or
symptom based
STI clinics attendees Routine testing as per clinical guidelines Increase detection of syphilis
infections
Reminders for clinicians (system
generated alerts) to include syphilis in
routine STI testing
Optimise screening rates and
increase testing frequency
Reminders for patients (e.g. SMS text,
telephone) to get screened or rescreened
2. Expanded testing in outreach venues
• Important to ensure links to healthcare services for the verification of positive screening tests,
reporting, treatment, and follow-up.
• Important to involve community organisations!
17
Source: ECDC Syphilis and congenital syphilis in Europe - A review of epidemiological trends (2007–2018) and options for response. 2019
Population Intervention Outcome
MSM (especially during outbreaks) Outreach testing
Increase syphilis detection among
individuals at risk that do not
regularly attend traditional healthcare
settings
Populations with inadequate access
to healthcare (e.g. ethnic minority
or marginalised populations)
Outreach testing
ECDC & EMCDDA guidance, 2018 - STI testing in prison settings recommended based on risk profile,
age-based and/or universal testing approaches
3. Partner management services
18
Source: ECDC Syphilis and congenital syphilis in Europe - A review of epidemiological trends (2007–2018) and options for response. 2019
Population Intervention Outcome
Settings that do not usually
provide partner services (e.g.
community based clinics)
Settings with high number of
syphilis cases
Placing staff trained in partner
management
OR
improving skills of existing staff
Improve performance of partner
identification and management
Setting quality standards and indicators
(e.g. no. of partners elicited/index patients,
no. of partners tested/index patients, no. of
partners treated)
Measure performance of partner
services
Using alternative tools for notifying and
locating contacts (e.g. internet-locating
information, online tools, smartphone
applications, Facebook)
Improve performance of partner
identification and management
Detailed technical guidelines: European guidelines for management of partners of persons with STI,
IUSTI; 2014 European Guideline on the Management of Syphilis
Population Intervention Outcome
Populations at high risk Educational, health-promotion
and awareness-raising activities Improve knowledge of syphilis,
recognition of symptoms,
increase testing uptakeAdolescents, young adults and
MSM
Social media platforms (e.g.
Facebook, Twitter, YouTube,
Instagram and dating apps)
Healthcare providers Education to maintain a suitable
level of knowledge and
awareness
Facilitate early recognition of
symptoms and atypical
presentations
Increase syphilis testing and
case detection
4. Education, health-promotion, awareness-raising
19
Source: ECDC Syphilis and congenital syphilis in Europe - A review of epidemiological trends (2007–2018) and options for response. 2019
Important! Evaluation of education campaigns outcomes is recommended due to
mixed impact reported.
Check Yourself: A Social Marketing Campaign to Increase
Syphilis Screening in Los Angeles County 2007-2009
Use of social media
20
To improve knowledge on syphilis and increase access to
testing.
As alternatives to traditional patient care pathways and
partner services.
Biomedical interventions
More evidence is needed on the long-term consequences of this strategy for syphilis and other
infections before considering widespread implementation.
21
Population Intervention Outcome
High-risk HIV-positive MSM (with ≥ 2
syphilis episodes since HIV diagnosis)
Bolan et al. 2015 US
Daily doxycycline (100 mg) vs
contingency management, 48 weeks
Reduction in STI incidence (OR = 0.27,
95% CI 0.09-0.83, p = 0.02) at week
48 for doxycycline group. Reduction in
syphilis (2 vs 6 cases).
High risk HIV-negative MSM under PrEP
Molina et al. 2018 France
Post-exposure doxycycline (200 mg,
single dose, oral) <24 h after
condomless sex (anal or oral), 10
months
Syphilis occurrence significantly
reduced in intervention group (HR
0.27; 95% CI 0.07-0.98, p=0.047).
More GI adverse events in intervention
group (53% vs 41%, p=0.05).
Interventions reported by 13/28 Member States -
2019 survey
• Implementation of a national STI strategy (stand-alone strategy or
integrated in sexual health or HIV/STI strategy), will ensure
commitment of stakeholders and resources.
• Development of national syphilis action plans and enhanced
surveillance activities.
• Sexual education in schools, shifting from an HIV focus to HIV and
STI.
• Increasing number of ‘checkpoints’ for low-threshold testing in
major cities, mostly targeting MSM.
• Communication on increases in syphilis infections in epidemiological
bulletins.
22
ECDC report published on 4 Sept 2019
Congenital syphilis, EU/EEA, 2007–2017
23
0
5
10
15
20
25
30
0
0.5
1
1.5
2
2.5
3
3.5
2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Numberofcountries
Numberofcasesper100000livebirths
Year
Countries reporting zero cases Countries reporting cases
Congenital syphilis rate
Sources: Bulgaria, Cyprus, the Czech Republic, Denmark, Estonia, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania,
Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden and the United Kingdom
Congenital syphilis levels in the
EU/EEA have been consistently
low.
To sustain these low rates:
• effective national antenatal
screening programmes
• interventions to control
syphilis transmission among
heterosexual populations.
24
“Categories of interventions have not changed much since Parran
described his approach to identifying, treating, and preventing
cases in the 1930s, but the specifics of how they are done will vary
depending on the goal, who is targeted, and opportunities.”
Peterman T. & Cha S. Context-Appropriate Interventions to Prevent Syphilis.
A Narrative Review. STD. 2018
The Battle Against Syphilis; Dr. Parran's "Shadow on
the Land" The New York Times Archives
What is new?
Acknowledgements
External reviewers of draft ECDC report: Raj Patel (IUSTI Europe), Magnus
Unemo (Sweden), Ian Simms (UK), Tom Peterman (USA), Melanie Taylor (WHO)
The EU/EEA STI network
ECDC colleagues: Ana-Belen Escriva, Anastasia Pharris, Caroline Daamen
Contact: Otilia.Mardh@ecdc.europa.eu; STIHIVHEP@ecdc.europa.eu
25

More Related Content

What's hot

Tuberculosis situation in the EU/EEA, 2018 - 2016 data
Tuberculosis situation in the EU/EEA, 2018 - 2016 dataTuberculosis situation in the EU/EEA, 2018 - 2016 data
Tuberculosis situation in the EU/EEA, 2018 - 2016 data
European Centre for Disease Prevention and Control
 
Whole Genome Sequencing in EU Multi-country Foodborne Outbreak Investigation
Whole Genome Sequencing in EU Multi-country Foodborne Outbreak InvestigationWhole Genome Sequencing in EU Multi-country Foodborne Outbreak Investigation
Whole Genome Sequencing in EU Multi-country Foodborne Outbreak Investigation
European Centre for Disease Prevention and Control
 
Surveillance of hepatitis B and C in the EU/EEA – 2017 data
Surveillance of hepatitis B and C in the EU/EEA – 2017 dataSurveillance of hepatitis B and C in the EU/EEA – 2017 data
Surveillance of hepatitis B and C in the EU/EEA – 2017 data
European Centre for Disease Prevention and Control
 
Annual Epidemiological Report for 2017: Sexually Transmitted Diseases
Annual Epidemiological Report for 2017: Sexually Transmitted DiseasesAnnual Epidemiological Report for 2017: Sexually Transmitted Diseases
Annual Epidemiological Report for 2017: Sexually Transmitted Diseases
European Centre for Disease Prevention and Control
 
Sexually transmitted infections, EU/EEA, 2016
Sexually transmitted infections, EU/EEA, 2016 Sexually transmitted infections, EU/EEA, 2016
Sexually transmitted infections, EU/EEA, 2016
European Centre for Disease Prevention and Control
 
What have we overlooked in the epidemiology of antimicrobial resistance in Eu...
What have we overlooked in the epidemiology of antimicrobial resistance in Eu...What have we overlooked in the epidemiology of antimicrobial resistance in Eu...
What have we overlooked in the epidemiology of antimicrobial resistance in Eu...
European Centre for Disease Prevention and Control
 
New HIV diagnoses among older adults in the EU/EEA: Missed opportunities and ...
New HIV diagnoses among older adults in the EU/EEA: Missed opportunities and ...New HIV diagnoses among older adults in the EU/EEA: Missed opportunities and ...
New HIV diagnoses among older adults in the EU/EEA: Missed opportunities and ...
European Centre for Disease Prevention and Control
 
Strategies to reduce HIV incidence in Europe
Strategies to reduce HIV incidence in EuropeStrategies to reduce HIV incidence in Europe
Strategies to reduce HIV incidence in Europe
European Centre for Disease Prevention and Control
 
HIV/AIDS surveillance in Europe 2018 (2017 data)
HIV/AIDS surveillance in Europe  2018 (2017 data)HIV/AIDS surveillance in Europe  2018 (2017 data)
HIV/AIDS surveillance in Europe 2018 (2017 data)
European Centre for Disease Prevention and Control
 
HIV AIDS Surveillance Report 2015
HIV AIDS Surveillance Report 2015HIV AIDS Surveillance Report 2015
HIV AIDS Surveillance Report 2015
European Centre for Disease Prevention and Control
 
HIV infection in children and adolescents in the EU/EEA 2015
HIV infection in children and adolescents in the EU/EEA 2015HIV infection in children and adolescents in the EU/EEA 2015
HIV infection in children and adolescents in the EU/EEA 2015
European Centre for Disease Prevention and Control
 
The attributable fraction of deaths due to viral hepatitis: results from a se...
The attributable fraction of deaths due to viral hepatitis: results from a se...The attributable fraction of deaths due to viral hepatitis: results from a se...
The attributable fraction of deaths due to viral hepatitis: results from a se...
European Centre for Disease Prevention and Control
 
Is shigellosis among MSM a widespread problem? An analysis of EU/EEA surveill...
Is shigellosis among MSM a widespread problem? An analysis of EU/EEA surveill...Is shigellosis among MSM a widespread problem? An analysis of EU/EEA surveill...
Is shigellosis among MSM a widespread problem? An analysis of EU/EEA surveill...
European Centre for Disease Prevention and Control
 
Sexually transmitted infections in Europe, 2013
Sexually transmitted infections in Europe, 2013Sexually transmitted infections in Europe, 2013
Sexually transmitted infections in Europe, 2013
European Centre for Disease Prevention and Control
 
Surveillance data on hepatitis B and C in EU/EEA 2014
Surveillance data on hepatitis B and C in EU/EEA 2014Surveillance data on hepatitis B and C in EU/EEA 2014
Surveillance data on hepatitis B and C in EU/EEA 2014
European Centre for Disease Prevention and Control
 
graphics trends for ecdc measles and rubella monitoring, 2013 2016
graphics trends for ecdc measles and rubella monitoring, 2013 2016graphics trends for ecdc measles and rubella monitoring, 2013 2016
graphics trends for ecdc measles and rubella monitoring, 2013 2016
European Centre for Disease Prevention and Control
 
How can HIV among men who have sex with men be prevented in Europe? Evidence-...
How can HIV among men who have sex with men be prevented in Europe? Evidence-...How can HIV among men who have sex with men be prevented in Europe? Evidence-...
How can HIV among men who have sex with men be prevented in Europe? Evidence-...
European Centre for Disease Prevention and Control
 
HIV: epidemiological challenges in Europe
HIV: epidemiological challenges in Europe HIV: epidemiological challenges in Europe
HIV: epidemiological challenges in Europe
European Centre for Disease Prevention and Control
 
HIV and AIDS surveillance in the EU/EEA
HIV and AIDS surveillance in the EU/EEAHIV and AIDS surveillance in the EU/EEA
HIV and AIDS surveillance in the EU/EEA
European Centre for Disease Prevention and Control
 
Surveillance of hepatitis B and C in the EU/EEA: 2013 data
Surveillance of hepatitis B and C in the EU/EEA: 2013 dataSurveillance of hepatitis B and C in the EU/EEA: 2013 data
Surveillance of hepatitis B and C in the EU/EEA: 2013 data
European Centre for Disease Prevention and Control
 

What's hot (20)

Tuberculosis situation in the EU/EEA, 2018 - 2016 data
Tuberculosis situation in the EU/EEA, 2018 - 2016 dataTuberculosis situation in the EU/EEA, 2018 - 2016 data
Tuberculosis situation in the EU/EEA, 2018 - 2016 data
 
Whole Genome Sequencing in EU Multi-country Foodborne Outbreak Investigation
Whole Genome Sequencing in EU Multi-country Foodborne Outbreak InvestigationWhole Genome Sequencing in EU Multi-country Foodborne Outbreak Investigation
Whole Genome Sequencing in EU Multi-country Foodborne Outbreak Investigation
 
Surveillance of hepatitis B and C in the EU/EEA – 2017 data
Surveillance of hepatitis B and C in the EU/EEA – 2017 dataSurveillance of hepatitis B and C in the EU/EEA – 2017 data
Surveillance of hepatitis B and C in the EU/EEA – 2017 data
 
Annual Epidemiological Report for 2017: Sexually Transmitted Diseases
Annual Epidemiological Report for 2017: Sexually Transmitted DiseasesAnnual Epidemiological Report for 2017: Sexually Transmitted Diseases
Annual Epidemiological Report for 2017: Sexually Transmitted Diseases
 
Sexually transmitted infections, EU/EEA, 2016
Sexually transmitted infections, EU/EEA, 2016 Sexually transmitted infections, EU/EEA, 2016
Sexually transmitted infections, EU/EEA, 2016
 
What have we overlooked in the epidemiology of antimicrobial resistance in Eu...
What have we overlooked in the epidemiology of antimicrobial resistance in Eu...What have we overlooked in the epidemiology of antimicrobial resistance in Eu...
What have we overlooked in the epidemiology of antimicrobial resistance in Eu...
 
New HIV diagnoses among older adults in the EU/EEA: Missed opportunities and ...
New HIV diagnoses among older adults in the EU/EEA: Missed opportunities and ...New HIV diagnoses among older adults in the EU/EEA: Missed opportunities and ...
New HIV diagnoses among older adults in the EU/EEA: Missed opportunities and ...
 
Strategies to reduce HIV incidence in Europe
Strategies to reduce HIV incidence in EuropeStrategies to reduce HIV incidence in Europe
Strategies to reduce HIV incidence in Europe
 
HIV/AIDS surveillance in Europe 2018 (2017 data)
HIV/AIDS surveillance in Europe  2018 (2017 data)HIV/AIDS surveillance in Europe  2018 (2017 data)
HIV/AIDS surveillance in Europe 2018 (2017 data)
 
HIV AIDS Surveillance Report 2015
HIV AIDS Surveillance Report 2015HIV AIDS Surveillance Report 2015
HIV AIDS Surveillance Report 2015
 
HIV infection in children and adolescents in the EU/EEA 2015
HIV infection in children and adolescents in the EU/EEA 2015HIV infection in children and adolescents in the EU/EEA 2015
HIV infection in children and adolescents in the EU/EEA 2015
 
The attributable fraction of deaths due to viral hepatitis: results from a se...
The attributable fraction of deaths due to viral hepatitis: results from a se...The attributable fraction of deaths due to viral hepatitis: results from a se...
The attributable fraction of deaths due to viral hepatitis: results from a se...
 
Is shigellosis among MSM a widespread problem? An analysis of EU/EEA surveill...
Is shigellosis among MSM a widespread problem? An analysis of EU/EEA surveill...Is shigellosis among MSM a widespread problem? An analysis of EU/EEA surveill...
Is shigellosis among MSM a widespread problem? An analysis of EU/EEA surveill...
 
Sexually transmitted infections in Europe, 2013
Sexually transmitted infections in Europe, 2013Sexually transmitted infections in Europe, 2013
Sexually transmitted infections in Europe, 2013
 
Surveillance data on hepatitis B and C in EU/EEA 2014
Surveillance data on hepatitis B and C in EU/EEA 2014Surveillance data on hepatitis B and C in EU/EEA 2014
Surveillance data on hepatitis B and C in EU/EEA 2014
 
graphics trends for ecdc measles and rubella monitoring, 2013 2016
graphics trends for ecdc measles and rubella monitoring, 2013 2016graphics trends for ecdc measles and rubella monitoring, 2013 2016
graphics trends for ecdc measles and rubella monitoring, 2013 2016
 
How can HIV among men who have sex with men be prevented in Europe? Evidence-...
How can HIV among men who have sex with men be prevented in Europe? Evidence-...How can HIV among men who have sex with men be prevented in Europe? Evidence-...
How can HIV among men who have sex with men be prevented in Europe? Evidence-...
 
HIV: epidemiological challenges in Europe
HIV: epidemiological challenges in Europe HIV: epidemiological challenges in Europe
HIV: epidemiological challenges in Europe
 
HIV and AIDS surveillance in the EU/EEA
HIV and AIDS surveillance in the EU/EEAHIV and AIDS surveillance in the EU/EEA
HIV and AIDS surveillance in the EU/EEA
 
Surveillance of hepatitis B and C in the EU/EEA: 2013 data
Surveillance of hepatitis B and C in the EU/EEA: 2013 dataSurveillance of hepatitis B and C in the EU/EEA: 2013 data
Surveillance of hepatitis B and C in the EU/EEA: 2013 data
 

Similar to The public health response to increasing syphilis trends in Europe

Hepatitis B and C surveillance in the EU/EEA, 2016 data
Hepatitis B and C surveillance in the EU/EEA, 2016 dataHepatitis B and C surveillance in the EU/EEA, 2016 data
Hepatitis B and C surveillance in the EU/EEA, 2016 data
European Centre for Disease Prevention and Control
 
HIV infection among persons aged 50 years and over in the EU, 2004–2013: miss...
HIV infection among persons aged 50 years and over in the EU, 2004–2013: miss...HIV infection among persons aged 50 years and over in the EU, 2004–2013: miss...
HIV infection among persons aged 50 years and over in the EU, 2004–2013: miss...
European Centre for Disease Prevention and Control
 
Hepatitis B and C surveillance in the EU/EEA 2015
Hepatitis B and C surveillance in the EU/EEA 2015Hepatitis B and C surveillance in the EU/EEA 2015
Hepatitis B and C surveillance in the EU/EEA 2015
European Centre for Disease Prevention and Control
 
Антиретровирусное лечение – перспективы Европейского клинического общества по...
Антиретровирусное лечение – перспективы Европейского клинического общества по...Антиретровирусное лечение – перспективы Европейского клинического общества по...
Антиретровирусное лечение – перспективы Европейского клинического общества по...
hivlifeinfo
 
Tuberculosis and HIV co-infection in the European Union: Epidemiology and tre...
Tuberculosis and HIV co-infection in the European Union: Epidemiology and tre...Tuberculosis and HIV co-infection in the European Union: Epidemiology and tre...
Tuberculosis and HIV co-infection in the European Union: Epidemiology and tre...
European Centre for Disease Prevention and Control
 
From Dublin to Rome: 10 years of the HIV epidemic and response in Europe
From Dublin to Rome: 10 years of the HIV epidemic and response in Europe From Dublin to Rome: 10 years of the HIV epidemic and response in Europe
From Dublin to Rome: 10 years of the HIV epidemic and response in Europe
European Centre for Disease Prevention and Control
 
6249919.ppt
6249919.ppt6249919.ppt
6249919.ppt
Esam43
 
1st Hepatitis E virus expert meeting at ECDC, Introduction
1st Hepatitis E virus expert meeting at ECDC, Introduction1st Hepatitis E virus expert meeting at ECDC, Introduction
1st Hepatitis E virus expert meeting at ECDC, Introduction
Cornelia Adlhoch
 
Community-based HIV testing: the Athens Checkpoint initiative
Community-based HIV testing: the Athens Checkpoint initiativeCommunity-based HIV testing: the Athens Checkpoint initiative
Community-based HIV testing: the Athens Checkpoint initiative
European Centre for Disease Prevention and Control
 
The meaning of meningococcal carriage - Slideset by Professor Adam Finn
The meaning of meningococcal carriage - Slideset by Professor Adam FinnThe meaning of meningococcal carriage - Slideset by Professor Adam Finn
The meaning of meningococcal carriage - Slideset by Professor Adam Finn
WAidid
 
Health at a Glance: Europe 2018 - State of Health in the EU Cycle - CHARTSET
Health at a Glance: Europe 2018 - State of Health in the EU Cycle - CHARTSETHealth at a Glance: Europe 2018 - State of Health in the EU Cycle - CHARTSET
Health at a Glance: Europe 2018 - State of Health in the EU Cycle - CHARTSET
OECD Directorate for Employment, Labour and Social Affairs
 
Public injecting, harm reduction services
Public injecting, harm reduction servicesPublic injecting, harm reduction services
Public injecting, harm reduction services
Jozsef Racz
 
Hiv aids-surveillance-report-2012
Hiv aids-surveillance-report-2012Hiv aids-surveillance-report-2012
Hiv aids-surveillance-report-2012
Gaby Frankfurt
 
Improving the understanding of chlamydia epidemiology in Europe - ESCR 2016
Improving the understanding of chlamydia epidemiology in Europe - ESCR 2016Improving the understanding of chlamydia epidemiology in Europe - ESCR 2016
Improving the understanding of chlamydia epidemiology in Europe - ESCR 2016
European Centre for Disease Prevention and Control
 
Chemsex - the 'ins and outs' of managing an outbreak: a local health protecti...
Chemsex - the 'ins and outs' of managing an outbreak: a local health protecti...Chemsex - the 'ins and outs' of managing an outbreak: a local health protecti...
Chemsex - the 'ins and outs' of managing an outbreak: a local health protecti...
UKFacultyPublicHealth
 
Fast-tracking the end of AIDS in Europe
Fast-tracking the end of AIDS in EuropeFast-tracking the end of AIDS in Europe
Fast-tracking the end of AIDS in Europe
European Centre for Disease Prevention and Control
 
Social determinants and risk factors for tuberculosis; need for harmonisation...
Social determinants and risk factors for tuberculosis; need for harmonisation...Social determinants and risk factors for tuberculosis; need for harmonisation...
Social determinants and risk factors for tuberculosis; need for harmonisation...
European Centre for Disease Prevention and Control
 
Latest epidemiology on migrants in the European Union - ECDC
Latest epidemiology on migrants in the European Union - ECDCLatest epidemiology on migrants in the European Union - ECDC
Latest epidemiology on migrants in the European Union - ECDC
European Centre for Disease Prevention and Control
 
Developing Urban Health Indicators for Low Income Countries: A Case Study
Developing Urban Health Indicators for Low Income Countries: A Case StudyDeveloping Urban Health Indicators for Low Income Countries: A Case Study
Developing Urban Health Indicators for Low Income Countries: A Case Study
steelss
 
Emerging and re-emerging infectious diseases: a key issue of governance for h...
Emerging and re-emerging infectious diseases: a key issue of governance for h...Emerging and re-emerging infectious diseases: a key issue of governance for h...
Emerging and re-emerging infectious diseases: a key issue of governance for h...
WHO Regional Office for Europe
 

Similar to The public health response to increasing syphilis trends in Europe (20)

Hepatitis B and C surveillance in the EU/EEA, 2016 data
Hepatitis B and C surveillance in the EU/EEA, 2016 dataHepatitis B and C surveillance in the EU/EEA, 2016 data
Hepatitis B and C surveillance in the EU/EEA, 2016 data
 
HIV infection among persons aged 50 years and over in the EU, 2004–2013: miss...
HIV infection among persons aged 50 years and over in the EU, 2004–2013: miss...HIV infection among persons aged 50 years and over in the EU, 2004–2013: miss...
HIV infection among persons aged 50 years and over in the EU, 2004–2013: miss...
 
Hepatitis B and C surveillance in the EU/EEA 2015
Hepatitis B and C surveillance in the EU/EEA 2015Hepatitis B and C surveillance in the EU/EEA 2015
Hepatitis B and C surveillance in the EU/EEA 2015
 
Антиретровирусное лечение – перспективы Европейского клинического общества по...
Антиретровирусное лечение – перспективы Европейского клинического общества по...Антиретровирусное лечение – перспективы Европейского клинического общества по...
Антиретровирусное лечение – перспективы Европейского клинического общества по...
 
Tuberculosis and HIV co-infection in the European Union: Epidemiology and tre...
Tuberculosis and HIV co-infection in the European Union: Epidemiology and tre...Tuberculosis and HIV co-infection in the European Union: Epidemiology and tre...
Tuberculosis and HIV co-infection in the European Union: Epidemiology and tre...
 
From Dublin to Rome: 10 years of the HIV epidemic and response in Europe
From Dublin to Rome: 10 years of the HIV epidemic and response in Europe From Dublin to Rome: 10 years of the HIV epidemic and response in Europe
From Dublin to Rome: 10 years of the HIV epidemic and response in Europe
 
6249919.ppt
6249919.ppt6249919.ppt
6249919.ppt
 
1st Hepatitis E virus expert meeting at ECDC, Introduction
1st Hepatitis E virus expert meeting at ECDC, Introduction1st Hepatitis E virus expert meeting at ECDC, Introduction
1st Hepatitis E virus expert meeting at ECDC, Introduction
 
Community-based HIV testing: the Athens Checkpoint initiative
Community-based HIV testing: the Athens Checkpoint initiativeCommunity-based HIV testing: the Athens Checkpoint initiative
Community-based HIV testing: the Athens Checkpoint initiative
 
The meaning of meningococcal carriage - Slideset by Professor Adam Finn
The meaning of meningococcal carriage - Slideset by Professor Adam FinnThe meaning of meningococcal carriage - Slideset by Professor Adam Finn
The meaning of meningococcal carriage - Slideset by Professor Adam Finn
 
Health at a Glance: Europe 2018 - State of Health in the EU Cycle - CHARTSET
Health at a Glance: Europe 2018 - State of Health in the EU Cycle - CHARTSETHealth at a Glance: Europe 2018 - State of Health in the EU Cycle - CHARTSET
Health at a Glance: Europe 2018 - State of Health in the EU Cycle - CHARTSET
 
Public injecting, harm reduction services
Public injecting, harm reduction servicesPublic injecting, harm reduction services
Public injecting, harm reduction services
 
Hiv aids-surveillance-report-2012
Hiv aids-surveillance-report-2012Hiv aids-surveillance-report-2012
Hiv aids-surveillance-report-2012
 
Improving the understanding of chlamydia epidemiology in Europe - ESCR 2016
Improving the understanding of chlamydia epidemiology in Europe - ESCR 2016Improving the understanding of chlamydia epidemiology in Europe - ESCR 2016
Improving the understanding of chlamydia epidemiology in Europe - ESCR 2016
 
Chemsex - the 'ins and outs' of managing an outbreak: a local health protecti...
Chemsex - the 'ins and outs' of managing an outbreak: a local health protecti...Chemsex - the 'ins and outs' of managing an outbreak: a local health protecti...
Chemsex - the 'ins and outs' of managing an outbreak: a local health protecti...
 
Fast-tracking the end of AIDS in Europe
Fast-tracking the end of AIDS in EuropeFast-tracking the end of AIDS in Europe
Fast-tracking the end of AIDS in Europe
 
Social determinants and risk factors for tuberculosis; need for harmonisation...
Social determinants and risk factors for tuberculosis; need for harmonisation...Social determinants and risk factors for tuberculosis; need for harmonisation...
Social determinants and risk factors for tuberculosis; need for harmonisation...
 
Latest epidemiology on migrants in the European Union - ECDC
Latest epidemiology on migrants in the European Union - ECDCLatest epidemiology on migrants in the European Union - ECDC
Latest epidemiology on migrants in the European Union - ECDC
 
Developing Urban Health Indicators for Low Income Countries: A Case Study
Developing Urban Health Indicators for Low Income Countries: A Case StudyDeveloping Urban Health Indicators for Low Income Countries: A Case Study
Developing Urban Health Indicators for Low Income Countries: A Case Study
 
Emerging and re-emerging infectious diseases: a key issue of governance for h...
Emerging and re-emerging infectious diseases: a key issue of governance for h...Emerging and re-emerging infectious diseases: a key issue of governance for h...
Emerging and re-emerging infectious diseases: a key issue of governance for h...
 

More from European Centre for Disease Prevention and Control

Respondent Driven Sampling
Respondent Driven Sampling Respondent Driven Sampling
Online Respondent-Driven Detection (RDD)
Online Respondent-Driven Detection (RDD)Online Respondent-Driven Detection (RDD)
Online Respondent-Driven Detection (RDD)
European Centre for Disease Prevention and Control
 
The use, and likelihood of using, HIV pre-exposure prophylaxis among men who ...
The use, and likelihood of using, HIV pre-exposure prophylaxis among men who ...The use, and likelihood of using, HIV pre-exposure prophylaxis among men who ...
The use, and likelihood of using, HIV pre-exposure prophylaxis among men who ...
European Centre for Disease Prevention and Control
 
Addressing the first 90: How can HIV testing more efficiently reach those in ...
Addressing the first 90: How can HIV testing more efficiently reach those in ...Addressing the first 90: How can HIV testing more efficiently reach those in ...
Addressing the first 90: How can HIV testing more efficiently reach those in ...
European Centre for Disease Prevention and Control
 
Addressing the second 90: How can treatment scale-up across the European regi...
Addressing the second 90: How can treatment scale-up across the European regi...Addressing the second 90: How can treatment scale-up across the European regi...
Addressing the second 90: How can treatment scale-up across the European regi...
European Centre for Disease Prevention and Control
 
Addressing the third 90: Improving clinical outcomes and retention in care
Addressing the third 90: Improving clinical outcomes and retention in careAddressing the third 90: Improving clinical outcomes and retention in care
Addressing the third 90: Improving clinical outcomes and retention in care
European Centre for Disease Prevention and Control
 
Overview of the HIV continuum of care in Europe and Central Asia, 2018
Overview of the HIV continuum of care in Europe and Central Asia, 2018Overview of the HIV continuum of care in Europe and Central Asia, 2018
Overview of the HIV continuum of care in Europe and Central Asia, 2018
European Centre for Disease Prevention and Control
 
Monitoring viral hepatitis elimination across EU/EEA countries
Monitoring viral hepatitis elimination across EU/EEA countriesMonitoring viral hepatitis elimination across EU/EEA countries
Monitoring viral hepatitis elimination across EU/EEA countries
European Centre for Disease Prevention and Control
 
Tuberculosis Action Plan for the WHO European Region 2016-2020 EU/EEA - 2016 ...
Tuberculosis Action Plan for the WHO European Region 2016-2020 EU/EEA - 2016 ...Tuberculosis Action Plan for the WHO European Region 2016-2020 EU/EEA - 2016 ...
Tuberculosis Action Plan for the WHO European Region 2016-2020 EU/EEA - 2016 ...
European Centre for Disease Prevention and Control
 
How are countries in Europe and Central Asia performing against the UNAIDS 90...
How are countries in Europe and Central Asia performing against the UNAIDS 90...How are countries in Europe and Central Asia performing against the UNAIDS 90...
How are countries in Europe and Central Asia performing against the UNAIDS 90...
European Centre for Disease Prevention and Control
 

More from European Centre for Disease Prevention and Control (10)

Respondent Driven Sampling
Respondent Driven Sampling Respondent Driven Sampling
Respondent Driven Sampling
 
Online Respondent-Driven Detection (RDD)
Online Respondent-Driven Detection (RDD)Online Respondent-Driven Detection (RDD)
Online Respondent-Driven Detection (RDD)
 
The use, and likelihood of using, HIV pre-exposure prophylaxis among men who ...
The use, and likelihood of using, HIV pre-exposure prophylaxis among men who ...The use, and likelihood of using, HIV pre-exposure prophylaxis among men who ...
The use, and likelihood of using, HIV pre-exposure prophylaxis among men who ...
 
Addressing the first 90: How can HIV testing more efficiently reach those in ...
Addressing the first 90: How can HIV testing more efficiently reach those in ...Addressing the first 90: How can HIV testing more efficiently reach those in ...
Addressing the first 90: How can HIV testing more efficiently reach those in ...
 
Addressing the second 90: How can treatment scale-up across the European regi...
Addressing the second 90: How can treatment scale-up across the European regi...Addressing the second 90: How can treatment scale-up across the European regi...
Addressing the second 90: How can treatment scale-up across the European regi...
 
Addressing the third 90: Improving clinical outcomes and retention in care
Addressing the third 90: Improving clinical outcomes and retention in careAddressing the third 90: Improving clinical outcomes and retention in care
Addressing the third 90: Improving clinical outcomes and retention in care
 
Overview of the HIV continuum of care in Europe and Central Asia, 2018
Overview of the HIV continuum of care in Europe and Central Asia, 2018Overview of the HIV continuum of care in Europe and Central Asia, 2018
Overview of the HIV continuum of care in Europe and Central Asia, 2018
 
Monitoring viral hepatitis elimination across EU/EEA countries
Monitoring viral hepatitis elimination across EU/EEA countriesMonitoring viral hepatitis elimination across EU/EEA countries
Monitoring viral hepatitis elimination across EU/EEA countries
 
Tuberculosis Action Plan for the WHO European Region 2016-2020 EU/EEA - 2016 ...
Tuberculosis Action Plan for the WHO European Region 2016-2020 EU/EEA - 2016 ...Tuberculosis Action Plan for the WHO European Region 2016-2020 EU/EEA - 2016 ...
Tuberculosis Action Plan for the WHO European Region 2016-2020 EU/EEA - 2016 ...
 
How are countries in Europe and Central Asia performing against the UNAIDS 90...
How are countries in Europe and Central Asia performing against the UNAIDS 90...How are countries in Europe and Central Asia performing against the UNAIDS 90...
How are countries in Europe and Central Asia performing against the UNAIDS 90...
 

Recently uploaded

Cervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptxCervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptx
LEFLOT Jean-Louis
 
pathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathologypathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathology
ZayedKhan38
 
Acute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdfAcute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdf
Jim Jacob Roy
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
AksshayaRajanbabu
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Jim Jacob Roy
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
reignlana06
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
19various
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
walterHu5
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptxCLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
Government Dental College & Hospital Srinagar
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
NephroTube - Dr.Gawad
 
Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024
Torstein Dalen-Lorentsen
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
FFragrant
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
Earlene McNair
 

Recently uploaded (20)

Cervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptxCervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptx
 
pathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathologypathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathology
 
Acute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdfAcute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdf
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptxCLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
 
Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
 

The public health response to increasing syphilis trends in Europe

  • 1. The public health response to increasing syphilis trends in Europe Otilia Mårdh, Gianfranco Spiteri, Aitana Morano-Vazquez, Andrew Amato ECDC IUSTI 2019, Tallinn S18 - ECDC Symposium: Responding to two of the main STI threats of our time: syphilis and antimicrobial resistant Neisseria gonorrhoeae
  • 2. Background • Since 2010, substantial increases in syphilis notifications rates in EU, mainly MSM; • Increasing trends and outbreaks also in other high-income countries (e.g. US, Japan, Canada, Australia) • September 2018 – request of Member States to ECDC (update on epidemiology, options for response) • July 2019 – ECDC technical report 2
  • 3. Methods Update on syphilis epidemiology Non-systematic literature review * 2007-2018 PubMed, Embase, Scopus Identify trends, describe recent outbreaks, identify drivers of syphilis epidemic Surveillance data analysis 2007-2017 ECDC TESSy Member States survey 2019 Changes in surveillance, recent data 3 *EU/EEA, EU candidate countries, high-income countries (Australia, Canada, Japan, New Zealand and the USA) Options for response Systematic literature review* 2007-2018 PubMed, Embase, Scopus, Cochrane, Google-, hand- searches Member States survey 2019 Models of practice Collect the evidence-base and formulate options for response Source: ECDC Syphilis and congenital syphilis in Europe - A review of epidemiological trends (2007–2018) and options for response. 2019 Objectives Outcomes
  • 4. Syphilis epidemiology, 2007-2018 EU/EEA and high income countries 4
  • 5. Syphilis EU/EEA, 2007-2017 5 0.0 2.0 4.0 6.0 8.0 10.0 12.0 14.0 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 Men Total Women *not from Liechtenstein Rates of syphilis infections per 100,000 population by year of notification, EU/EEA countries Note: includes reports from countries with comprehensive surveillance systems and consistent reporting over the period: Bulgaria, Cyprus, the Czech Republic, Denmark, Estonia, Finland, Germany, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden and the United Kingdom. Source: ECDC Surveillance Atlas https://atlas.ecdc.europa.eu/public/index.aspx • 260,505 syphilis cases, 30/31 Member States* • EU/EEA rate from 4.6 in 2007 to 7.1 in 2017
  • 6. • 260,505 syphilis cases, 30/31 Member States* • EU/EEA rate from 4.6 in 2007 to 7.1 in 2017 • M:F 3 in 2007 to 8.5 in 2017 Syphilis EU/EEA, 2007-2017 6 0.0 2.0 4.0 6.0 8.0 10.0 12.0 14.0 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 Men Total Women *not from Liechtenstein Rates of syphilis infections per 100,000 population by year of notification, EU/EEA countries Note: includes reports from countries with comprehensive surveillance systems and consistent reporting over the period: Bulgaria, Cyprus, the Czech Republic, Denmark, Estonia, Finland, Germany, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden and the United Kingdom. Source: ECDC Surveillance Atlas https://atlas.ecdc.europa.eu/public/index.aspx
  • 7. 0 2000 4000 6000 8000 10000 12000 14000 16000 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 Numberofcases MSM Heterosexual men Women Syphilis EU/EEA, 2007-2017 7 Number of syphilis infections by route of transmission* Note: includes reports from Cyprus, the Czech Republic, Denmark, France, Germany, Iceland, Ireland, Latvia, Lithuania, Malta, the Netherlands, Norway, Romania, Slovenia, Sweden and the United Kingdom. *Reported for 152,233 (58%) cases Overall, 2007-2017 MSM 62% 94,015 Heterosexual men 23% 35,633 Women 15% 22,242 Source: ECDC Surveillance Atlas https://atlas.ecdc.europa.eu/public/index.aspx
  • 8. Syphilis EU/EEA, 2014- 2017 2014 2015 2016 2017 Women 2.6% 2.1% 3.1% 1.8% Heterosexual men 12% 12% 10% 10% MSM 45% 44% 41% 39% 8 HIV co-infection *includes 39,340 cases with known HIV status reported as MSM, heterosexual men and heterosexual women between 2014-2017. Source: ECDC Surveillance Atlas https://atlas.ecdc.europa.eu/public/index.aspx Percentage HIV-positive syphilis cases* 0 1000 2000 3000 4000 5000 6000 2014 2015 2016 2017 Numberofcases MSM HIV- MSM HIV+ Number of syphilis infections by HIV-status among MSM
  • 9. Syphilis EU/EEA, 2014-2017 9 0% 10% 20% 30% 40% 50% 60% Women (n=3,986) Heterosexual men (n=6,136) MSM (n=24,278) Percentage Primary Secondary Early latent Late latent Latent (unknown duration) Stage of syphilis infection at diagnosis Note: includes reports from the Czech Republic, France, Hungary, Iceland, Ireland, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Norway, Portugal, Romania, Slovakia, Slovenia, Sweden, the United Kingdom • Most cases reported as early latent infection • 49% of women as early latent infections • Primary stage: 35% MSM, 31% MSW, 15% WSM Source: ECDC Surveillance Atlas https://atlas.ecdc.europa.eu/public/index.aspx
  • 10. 10 Literature review on syphilis epidemiology Studies reporting increasing trends and outbreaks by country and year of publication Note: search conducted in PubMed, Embase, Scopus 2007-2018; studies from the EU/EEA, EU candidate countries, high-income countries: Australia, Canada, Japan, New Zealand and the USA. Five studies with multi-country coverage not represented. Trends Outbreaks Australia 3 3 Canada 3 2 Switzerland 1 Czech Republic 1 Germany 2 Spain 7 Finland 1 France 2 Greece 1 2 Ireland 1 Japan 1 Netherlands 1 1 New Zeeland 3 Poland 1 Portugal 1 Romania 2 Serbia 1 UK 8 13 USA 20 7 Total 59 29 Source: ECDC Syphilis and congenital syphilis in Europe - A review of epidemiological trends (2007–2018) and options for response. 2019 • 19 countries, 14 European
  • 11. 11 Literature review on syphilis epidemiology Studies reporting increasing trends/outbreaks by risk group, country and year of publication Note: search conducted in PubMed, Embase, Scopus 2007-2018; studies from the EU/EEA, EU candidate countries, high-income countries: Australia, Canada, Japan, New Zealand and the USA. * Other includes: sex workers, military, blood donors, prisoners, PWID Heterosexuals HIV-positive Migrants MSM,bisexuals Other* Pregnantwomen Albania 2 Belgium 1 Canada 2 1 France 1 1 Germany 2 2 Greece 1 Ireland 1 Italy 1 1 2 Poland 2 2 Romania 1 Serbia 1 Spain 3 2 2 1 Sweden 1 Switzerland 2 1 Netherlands 2 UK 1 3 USA 6 8 7 4 3 Total 6 21 5 17 13 8 Source: ECDC Syphilis and congenital syphilis in Europe - A review of epidemiological trends (2007–2018) and options for response. 2019 • 68 studies, 17 countries
  • 12. Factors driving syphilis increases in EU/EEA and high income countries, 2007-2018, literature review results • high rates of condomless sex • increased number of sex partners (HIV- negative MSM) • serosorting (HIV-positive MSM) • impact of PrEP for HIV • use of social networking sites or mobile device application 12 Source: ECDC Syphilis and congenital syphilis in Europe - A review of epidemiological trends (2007–2018) and options for response. 2019 • condomless sex • multiple sex partners • substance use (drug or alcohol) • young age • history of incarceration • sex work • previous STI • social vulnerabilities (e.g. poverty, homelessness, ethnic minority, migrant or refugee status) MSM Heterosexual men and women
  • 13. Katsushika Hokusai. The Great Wave off Kanagawa Options for response How can we turn the tide? 13 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
  • 14. 14 0 2 4 6 8 10 12 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 No.ofstudies Year of publication Biomedical interventions Interventions using social media Education Partner notification Outreach venues testing Screening Source: ECDC Syphilis and congenital syphilis in Europe - A review of epidemiological trends (2007–2018) and options for response. 2019 Screening Outreachvenuestesting Partnernotification Education Socialmedia Biomedical Australia 5 3 1 France 1 Ireland 1 Netherlands 1 New Zeeland 1 UK 1 4 1 USA 8 1 6 11 4 1 Total 15 5 6 15 6 3 Systematic literature review on response interventions Studies reporting single interventions with a documented impact among adult populations Note: search conducted in PubMed, Embase, Scopus, CDSR, Google, hand searches; studies from the EU/EEA, EU candidate countries, high-income countries: Australia, Canada, Japan, New Zealand and the USA. Nine other studies reporting multiple interventions for outbreak response summarised in the report. • 50 studies, 7 countries
  • 15. Public health responses to increases in syphilis should aim to identify and treat syphilis cases and prevent new infections. Combining, 15 Case finding Screening/testing Partner notification and management Surveillance Case management Appropriate treatment Risk reduction counseling Education General population Populations at higher risk Healthcare providers Source: ECDC Syphilis and congenital syphilis in Europe - A review of epidemiological trends (2007–2018) and options for response. 2019    
  • 16. 1. Enhanced screening of populations at risk Testing of other risk groups e.g. ethnic minorities, marginalised populations, sex workers, PWID - to be informed by local epidemiology 16 Source: ECDC Syphilis and congenital syphilis in Europe - A review of epidemiological trends (2007–2018) and options for response. 2019 Population Intervention Outcome HIV-positive MSM Include syphilis testing in routine HIV clinical monitoring, 3- or 6-monthly, opt- out vs risk based Increase detection of early/asymptomatic syphilis infections HIV-negative MSM • with high no. of sex partners • PrEP users • with prior syphilis diagnosis Quarterly testing vs. bi-annual or symptom based STI clinics attendees Routine testing as per clinical guidelines Increase detection of syphilis infections Reminders for clinicians (system generated alerts) to include syphilis in routine STI testing Optimise screening rates and increase testing frequency Reminders for patients (e.g. SMS text, telephone) to get screened or rescreened
  • 17. 2. Expanded testing in outreach venues • Important to ensure links to healthcare services for the verification of positive screening tests, reporting, treatment, and follow-up. • Important to involve community organisations! 17 Source: ECDC Syphilis and congenital syphilis in Europe - A review of epidemiological trends (2007–2018) and options for response. 2019 Population Intervention Outcome MSM (especially during outbreaks) Outreach testing Increase syphilis detection among individuals at risk that do not regularly attend traditional healthcare settings Populations with inadequate access to healthcare (e.g. ethnic minority or marginalised populations) Outreach testing ECDC & EMCDDA guidance, 2018 - STI testing in prison settings recommended based on risk profile, age-based and/or universal testing approaches
  • 18. 3. Partner management services 18 Source: ECDC Syphilis and congenital syphilis in Europe - A review of epidemiological trends (2007–2018) and options for response. 2019 Population Intervention Outcome Settings that do not usually provide partner services (e.g. community based clinics) Settings with high number of syphilis cases Placing staff trained in partner management OR improving skills of existing staff Improve performance of partner identification and management Setting quality standards and indicators (e.g. no. of partners elicited/index patients, no. of partners tested/index patients, no. of partners treated) Measure performance of partner services Using alternative tools for notifying and locating contacts (e.g. internet-locating information, online tools, smartphone applications, Facebook) Improve performance of partner identification and management Detailed technical guidelines: European guidelines for management of partners of persons with STI, IUSTI; 2014 European Guideline on the Management of Syphilis
  • 19. Population Intervention Outcome Populations at high risk Educational, health-promotion and awareness-raising activities Improve knowledge of syphilis, recognition of symptoms, increase testing uptakeAdolescents, young adults and MSM Social media platforms (e.g. Facebook, Twitter, YouTube, Instagram and dating apps) Healthcare providers Education to maintain a suitable level of knowledge and awareness Facilitate early recognition of symptoms and atypical presentations Increase syphilis testing and case detection 4. Education, health-promotion, awareness-raising 19 Source: ECDC Syphilis and congenital syphilis in Europe - A review of epidemiological trends (2007–2018) and options for response. 2019 Important! Evaluation of education campaigns outcomes is recommended due to mixed impact reported. Check Yourself: A Social Marketing Campaign to Increase Syphilis Screening in Los Angeles County 2007-2009
  • 20. Use of social media 20 To improve knowledge on syphilis and increase access to testing. As alternatives to traditional patient care pathways and partner services.
  • 21. Biomedical interventions More evidence is needed on the long-term consequences of this strategy for syphilis and other infections before considering widespread implementation. 21 Population Intervention Outcome High-risk HIV-positive MSM (with ≥ 2 syphilis episodes since HIV diagnosis) Bolan et al. 2015 US Daily doxycycline (100 mg) vs contingency management, 48 weeks Reduction in STI incidence (OR = 0.27, 95% CI 0.09-0.83, p = 0.02) at week 48 for doxycycline group. Reduction in syphilis (2 vs 6 cases). High risk HIV-negative MSM under PrEP Molina et al. 2018 France Post-exposure doxycycline (200 mg, single dose, oral) <24 h after condomless sex (anal or oral), 10 months Syphilis occurrence significantly reduced in intervention group (HR 0.27; 95% CI 0.07-0.98, p=0.047). More GI adverse events in intervention group (53% vs 41%, p=0.05).
  • 22. Interventions reported by 13/28 Member States - 2019 survey • Implementation of a national STI strategy (stand-alone strategy or integrated in sexual health or HIV/STI strategy), will ensure commitment of stakeholders and resources. • Development of national syphilis action plans and enhanced surveillance activities. • Sexual education in schools, shifting from an HIV focus to HIV and STI. • Increasing number of ‘checkpoints’ for low-threshold testing in major cities, mostly targeting MSM. • Communication on increases in syphilis infections in epidemiological bulletins. 22 ECDC report published on 4 Sept 2019
  • 23. Congenital syphilis, EU/EEA, 2007–2017 23 0 5 10 15 20 25 30 0 0.5 1 1.5 2 2.5 3 3.5 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 Numberofcountries Numberofcasesper100000livebirths Year Countries reporting zero cases Countries reporting cases Congenital syphilis rate Sources: Bulgaria, Cyprus, the Czech Republic, Denmark, Estonia, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden and the United Kingdom Congenital syphilis levels in the EU/EEA have been consistently low. To sustain these low rates: • effective national antenatal screening programmes • interventions to control syphilis transmission among heterosexual populations.
  • 24. 24 “Categories of interventions have not changed much since Parran described his approach to identifying, treating, and preventing cases in the 1930s, but the specifics of how they are done will vary depending on the goal, who is targeted, and opportunities.” Peterman T. & Cha S. Context-Appropriate Interventions to Prevent Syphilis. A Narrative Review. STD. 2018 The Battle Against Syphilis; Dr. Parran's "Shadow on the Land" The New York Times Archives What is new?
  • 25. Acknowledgements External reviewers of draft ECDC report: Raj Patel (IUSTI Europe), Magnus Unemo (Sweden), Ian Simms (UK), Tom Peterman (USA), Melanie Taylor (WHO) The EU/EEA STI network ECDC colleagues: Ana-Belen Escriva, Anastasia Pharris, Caroline Daamen Contact: Otilia.Mardh@ecdc.europa.eu; STIHIVHEP@ecdc.europa.eu 25